Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-12

AUTHORS

Yun Fan, Andrew S. Artz, Koen van Besien, Wendy Stock, Richard A. Larson, Olatoyosi Odenike, Lucy A. Godley, Justin Kline, John M. Cunningham, James L. LaBelle, Michael R. Bishop, Hongtao Liu

ABSTRACT

Background: Second allogeneic hematopoietic stem cell transplant (HCT) remains as an option for disease relapse after initial HCT. Methods: We analyzed retrospectively the outcomes of 65 consecutive patients who underwent a second HCT for disease relapse at the University of Chicago. Univariate and multivariate analysis were conducted, and a scoring system was generated to select the patients who would benefit second HCT. Results: All except four patients received T cell depleted (TCD) first HCT. The majority of patients had AML (n = 47) and high risk MDS (n = 5). The median age at second HCT was 45 years (11-73). 13 patients (20%) achieved CR before second HCT. 98% (n = 64) and 72% (n = 47) patients achieved neutrophil and platelet engraftment at a median interval of 10 and 18 days, respectively, following the second HCT. With a median follow up of 23 (5.5-140) months for survivors after second HCT, the estimated 2 years PFS was 17.5% and the 2 years OS was 22.6%. The day 100 cumulative incidence of non-relapse mortality rate was 23.6%, and the cumulative incidence of aGVHD and cGVHD were 16.9% and 7.7% respectively at 1 year after second HCT. In univariate analysis, patients with remission duration after first HCT of > 12 months and those in CR before second HCT had significantly better PFS and OS. A scoring system using disease status before second HCT (CR = 0 vs. non-CR = 1), and remission duration after first HCT (< 6 = 2, 6-12 = 1 and > 12 months = 0) was generated as an approach to classify patients into different risk categories in the purpose to provide guidance to the transplant physician to inform the outcomes to potential patients undergoing 2nd HCT. A score of < 2 (n = 26) identified a group with PFS and OS of 31.6% and 36.2% at 2 years after second HCT. Conclusion: In conclusion, second HCT is a viable option for disease relapse after TCD HCT for patients entering second HCT in remission and/or remission duration > 12 months after first HCT with acceptable rates of GVHD and donor engraftment. More... »

PAGES

1

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s40164-018-0125-6

DOI

http://dx.doi.org/10.1186/s40164-018-0125-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111064138

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30622841


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Beijing Hospital", 
          "id": "https://www.grid.ac/institutes/grid.414350.7", 
          "name": [
            "Department of Hematology, Beijing Hospital, Beijing, China"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fan", 
        "givenName": "Yun", 
        "id": "sg:person.01221661073.53", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221661073.53"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Artz", 
        "givenName": "Andrew S.", 
        "id": "sg:person.01341031234.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341031234.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cornell University", 
          "id": "https://www.grid.ac/institutes/grid.5386.8", 
          "name": [
            "Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "van Besien", 
        "givenName": "Koen", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stock", 
        "givenName": "Wendy", 
        "id": "sg:person.0661605515.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661605515.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Larson", 
        "givenName": "Richard A.", 
        "id": "sg:person.011155432117.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011155432117.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Odenike", 
        "givenName": "Olatoyosi", 
        "id": "sg:person.01110341602.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110341602.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Godley", 
        "givenName": "Lucy A.", 
        "id": "sg:person.01154534615.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154534615.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kline", 
        "givenName": "Justin", 
        "id": "sg:person.01222650015.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222650015.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Comer Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.428125.8", 
          "name": [
            "Department of Pediatrics, University of Chicago Comer Children\u2019s Hospital, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cunningham", 
        "givenName": "John M.", 
        "id": "sg:person.013501676762.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013501676762.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Comer Children's Hospital", 
          "id": "https://www.grid.ac/institutes/grid.428125.8", 
          "name": [
            "Department of Pediatrics, University of Chicago Comer Children\u2019s Hospital, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "LaBelle", 
        "givenName": "James L.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bishop", 
        "givenName": "Michael R.", 
        "id": "sg:person.01301567366.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301567366.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Chicago Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.412578.d", 
          "name": [
            "Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Liu", 
        "givenName": "Hongtao", 
        "id": "sg:person.016023575313.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016023575313.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/j.bbmt.2009.01.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001645553"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007537088", 
          "https://doi.org/10.1038/sj.bmt.1705011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1705011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007537088", 
          "https://doi.org/10.1038/sj.bmt.1705011"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/eci.11.24", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008619233"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2014.10.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017028738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2014.9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021248967", 
          "https://doi.org/10.1038/bmt.2014.9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1704645", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026328513", 
          "https://doi.org/10.1038/sj.bmt.1704645"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2015.221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026646910", 
          "https://doi.org/10.1038/bmt.2015.221"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bmt.2015.186", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027828071", 
          "https://doi.org/10.1038/bmt.2015.186"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2015.11.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027956601"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.67.1875", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035196420"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.beha.2013.10.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043563683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-08-375840", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046279984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2011-01-332007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048048828"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2009.10.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049934487"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70225-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050030568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbmt.2016.12.633", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051575972"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.16.3675", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074864911"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1993.11.2.304", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1082801871"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-12", 
    "datePublishedReg": "2019-12-01", 
    "description": "Background: Second allogeneic hematopoietic stem cell transplant (HCT) remains as an option for disease relapse after initial HCT.\nMethods: We analyzed retrospectively the outcomes of 65 consecutive patients who underwent a second HCT for disease relapse at the University of Chicago. Univariate and multivariate analysis were conducted, and a scoring system was generated to select the patients who would benefit second HCT.\nResults: All except four patients received T cell depleted (TCD) first HCT. The majority of patients had AML (n\u2009=\u200947) and high risk MDS (n\u2009=\u20095). The median age at second HCT was 45\u00a0years (11-73). 13 patients (20%) achieved CR before second HCT. 98% (n\u2009=\u200964) and 72% (n\u2009=\u200947) patients achieved neutrophil and platelet engraftment at a median interval of 10 and 18\u00a0days, respectively, following the second HCT. With a median follow up of 23 (5.5-140) months for survivors after second HCT, the estimated 2\u00a0years PFS was 17.5% and the 2\u00a0years OS was 22.6%. The day 100 cumulative incidence of non-relapse mortality rate was 23.6%, and the cumulative incidence of aGVHD and cGVHD were 16.9% and 7.7% respectively at 1\u00a0year after second HCT. In univariate analysis, patients with remission duration after first HCT of >\u200912\u00a0months and those in CR before second HCT had significantly better PFS and OS. A scoring system using disease status before second HCT (CR\u2009=\u20090 vs. non-CR\u2009=\u20091), and remission duration after first HCT (<\u20096\u2009=\u20092, 6-12\u2009=\u20091 and\u2009>\u200912\u00a0months\u2009=\u20090) was generated as an approach to classify patients into different risk categories in the purpose to provide guidance to the transplant physician to inform the outcomes to potential patients undergoing 2nd HCT. A score of <\u20092 (n\u2009=\u200926) identified a group with PFS and OS of 31.6% and 36.2% at 2\u00a0years after second HCT.\nConclusion: In conclusion, second HCT is a viable option for disease relapse after TCD HCT for patients entering second HCT in remission and/or remission duration >\u200912\u00a0months after first HCT with acceptable rates of GVHD and donor engraftment.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s40164-018-0125-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1047344", 
        "issn": [
          "2162-3619"
        ], 
        "name": "Experimental Hematology & Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "8"
      }
    ], 
    "name": "Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant", 
    "pagination": "1", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "89b29599ebe46c8db82adcc86f9898186eca3b4f8d41a5e46f2d09d26ec0bcf6"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30622841"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101590676"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s40164-018-0125-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111064138"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s40164-018-0125-6", 
      "https://app.dimensions.ai/details/publication/pub.1111064138"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T08:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000314_0000000314/records_55838_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs40164-018-0125-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s40164-018-0125-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s40164-018-0125-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s40164-018-0125-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s40164-018-0125-6'


 

This table displays all metadata directly associated to this object as RDF triples.

211 TRIPLES      21 PREDICATES      47 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s40164-018-0125-6 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N5d42077ce9274cbf9c851d048f6dabc5
4 schema:citation sg:pub.10.1038/bmt.2014.9
5 sg:pub.10.1038/bmt.2015.186
6 sg:pub.10.1038/bmt.2015.221
7 sg:pub.10.1038/sj.bmt.1704645
8 sg:pub.10.1038/sj.bmt.1705011
9 https://doi.org/10.1016/j.bbmt.2009.01.021
10 https://doi.org/10.1016/j.bbmt.2009.10.023
11 https://doi.org/10.1016/j.bbmt.2014.10.006
12 https://doi.org/10.1016/j.bbmt.2015.11.012
13 https://doi.org/10.1016/j.bbmt.2016.12.633
14 https://doi.org/10.1016/j.beha.2013.10.008
15 https://doi.org/10.1016/s1470-2045(09)70225-6
16 https://doi.org/10.1182/blood-2011-01-332007
17 https://doi.org/10.1182/blood-2011-08-375840
18 https://doi.org/10.1200/jco.1993.11.2.304
19 https://doi.org/10.1200/jco.2001.19.16.3675
20 https://doi.org/10.1200/jco.2016.67.1875
21 https://doi.org/10.1586/eci.11.24
22 schema:datePublished 2019-12
23 schema:datePublishedReg 2019-12-01
24 schema:description Background: Second allogeneic hematopoietic stem cell transplant (HCT) remains as an option for disease relapse after initial HCT. Methods: We analyzed retrospectively the outcomes of 65 consecutive patients who underwent a second HCT for disease relapse at the University of Chicago. Univariate and multivariate analysis were conducted, and a scoring system was generated to select the patients who would benefit second HCT. Results: All except four patients received T cell depleted (TCD) first HCT. The majority of patients had AML (n = 47) and high risk MDS (n = 5). The median age at second HCT was 45 years (11-73). 13 patients (20%) achieved CR before second HCT. 98% (n = 64) and 72% (n = 47) patients achieved neutrophil and platelet engraftment at a median interval of 10 and 18 days, respectively, following the second HCT. With a median follow up of 23 (5.5-140) months for survivors after second HCT, the estimated 2 years PFS was 17.5% and the 2 years OS was 22.6%. The day 100 cumulative incidence of non-relapse mortality rate was 23.6%, and the cumulative incidence of aGVHD and cGVHD were 16.9% and 7.7% respectively at 1 year after second HCT. In univariate analysis, patients with remission duration after first HCT of > 12 months and those in CR before second HCT had significantly better PFS and OS. A scoring system using disease status before second HCT (CR = 0 vs. non-CR = 1), and remission duration after first HCT (< 6 = 2, 6-12 = 1 and > 12 months = 0) was generated as an approach to classify patients into different risk categories in the purpose to provide guidance to the transplant physician to inform the outcomes to potential patients undergoing 2nd HCT. A score of < 2 (n = 26) identified a group with PFS and OS of 31.6% and 36.2% at 2 years after second HCT. Conclusion: In conclusion, second HCT is a viable option for disease relapse after TCD HCT for patients entering second HCT in remission and/or remission duration > 12 months after first HCT with acceptable rates of GVHD and donor engraftment.
25 schema:genre research_article
26 schema:inLanguage en
27 schema:isAccessibleForFree true
28 schema:isPartOf Nd7036315b7514955920c183a599c79a7
29 Nfb6d4d82e98f443896a9ecbc6b8c4de5
30 sg:journal.1047344
31 schema:name Outcomes following second allogeneic stem cell transplant for disease relapse after T cell depleted transplant correlate with remission status and remission duration after the first transplant
32 schema:pagination 1
33 schema:productId N065289156d9d406ba9a9238889e28865
34 N171b39b1f30b4aac8af6b0f93cc7d062
35 N1efec7e5784c494a9f840e662327440e
36 N39fdc4a5f7124d0e8f2d49316b19fb55
37 N556962029e304617aa8c5a41eefa6377
38 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111064138
39 https://doi.org/10.1186/s40164-018-0125-6
40 schema:sdDatePublished 2019-04-11T08:36
41 schema:sdLicense https://scigraph.springernature.com/explorer/license/
42 schema:sdPublisher N186165be98714cfa8190310b97d03571
43 schema:url https://link.springer.com/10.1186%2Fs40164-018-0125-6
44 sgo:license sg:explorer/license/
45 sgo:sdDataset articles
46 rdf:type schema:ScholarlyArticle
47 N065289156d9d406ba9a9238889e28865 schema:name pubmed_id
48 schema:value 30622841
49 rdf:type schema:PropertyValue
50 N07558b8cfa0045c4965394ff67f24b9b rdf:first sg:person.01154534615.37
51 rdf:rest N979305ced9e74dbe88d079aca7b58b2d
52 N11d6830e0f834569b0847f87c30f5604 rdf:first sg:person.011155432117.78
53 rdf:rest Nc08c9117c9ea4a828ad041fcb797cbfc
54 N171b39b1f30b4aac8af6b0f93cc7d062 schema:name dimensions_id
55 schema:value pub.1111064138
56 rdf:type schema:PropertyValue
57 N186165be98714cfa8190310b97d03571 schema:name Springer Nature - SN SciGraph project
58 rdf:type schema:Organization
59 N1a5eda9fde3e47cfa3b15bc41e885496 rdf:first N98d2084ca4b34a6e9fa79d169ed9950a
60 rdf:rest N60e3869274ce4e4db7eaed24fb99fb20
61 N1efec7e5784c494a9f840e662327440e schema:name readcube_id
62 schema:value 89b29599ebe46c8db82adcc86f9898186eca3b4f8d41a5e46f2d09d26ec0bcf6
63 rdf:type schema:PropertyValue
64 N39fdc4a5f7124d0e8f2d49316b19fb55 schema:name doi
65 schema:value 10.1186/s40164-018-0125-6
66 rdf:type schema:PropertyValue
67 N556962029e304617aa8c5a41eefa6377 schema:name nlm_unique_id
68 schema:value 101590676
69 rdf:type schema:PropertyValue
70 N5922aeb9d6cf457a84d0085d63dc72d8 rdf:first sg:person.013501676762.51
71 rdf:rest N1a5eda9fde3e47cfa3b15bc41e885496
72 N5d42077ce9274cbf9c851d048f6dabc5 rdf:first sg:person.01221661073.53
73 rdf:rest N93c822c32aaa425cb29f539843f41833
74 N60e3869274ce4e4db7eaed24fb99fb20 rdf:first sg:person.01301567366.50
75 rdf:rest N65f85a6e454141609f10fe80709dd171
76 N65f85a6e454141609f10fe80709dd171 rdf:first sg:person.016023575313.55
77 rdf:rest rdf:nil
78 N69236d9e456d4835931af64c3535e566 rdf:first sg:person.0661605515.11
79 rdf:rest N11d6830e0f834569b0847f87c30f5604
80 N93c822c32aaa425cb29f539843f41833 rdf:first sg:person.01341031234.28
81 rdf:rest N98e3e3c320b547d1940beccc6f4ae874
82 N979305ced9e74dbe88d079aca7b58b2d rdf:first sg:person.01222650015.14
83 rdf:rest N5922aeb9d6cf457a84d0085d63dc72d8
84 N98d2084ca4b34a6e9fa79d169ed9950a schema:affiliation https://www.grid.ac/institutes/grid.428125.8
85 schema:familyName LaBelle
86 schema:givenName James L.
87 rdf:type schema:Person
88 N98e3e3c320b547d1940beccc6f4ae874 rdf:first Nd488e4808415402585a172b6b6ea8568
89 rdf:rest N69236d9e456d4835931af64c3535e566
90 Nc08c9117c9ea4a828ad041fcb797cbfc rdf:first sg:person.01110341602.27
91 rdf:rest N07558b8cfa0045c4965394ff67f24b9b
92 Nd488e4808415402585a172b6b6ea8568 schema:affiliation https://www.grid.ac/institutes/grid.5386.8
93 schema:familyName van Besien
94 schema:givenName Koen
95 rdf:type schema:Person
96 Nd7036315b7514955920c183a599c79a7 schema:issueNumber 1
97 rdf:type schema:PublicationIssue
98 Nfb6d4d82e98f443896a9ecbc6b8c4de5 schema:volumeNumber 8
99 rdf:type schema:PublicationVolume
100 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
101 schema:name Medical and Health Sciences
102 rdf:type schema:DefinedTerm
103 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
104 schema:name Clinical Sciences
105 rdf:type schema:DefinedTerm
106 sg:journal.1047344 schema:issn 2162-3619
107 schema:name Experimental Hematology & Oncology
108 rdf:type schema:Periodical
109 sg:person.01110341602.27 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
110 schema:familyName Odenike
111 schema:givenName Olatoyosi
112 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01110341602.27
113 rdf:type schema:Person
114 sg:person.011155432117.78 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
115 schema:familyName Larson
116 schema:givenName Richard A.
117 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011155432117.78
118 rdf:type schema:Person
119 sg:person.01154534615.37 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
120 schema:familyName Godley
121 schema:givenName Lucy A.
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01154534615.37
123 rdf:type schema:Person
124 sg:person.01221661073.53 schema:affiliation https://www.grid.ac/institutes/grid.414350.7
125 schema:familyName Fan
126 schema:givenName Yun
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01221661073.53
128 rdf:type schema:Person
129 sg:person.01222650015.14 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
130 schema:familyName Kline
131 schema:givenName Justin
132 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01222650015.14
133 rdf:type schema:Person
134 sg:person.01301567366.50 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
135 schema:familyName Bishop
136 schema:givenName Michael R.
137 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01301567366.50
138 rdf:type schema:Person
139 sg:person.01341031234.28 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
140 schema:familyName Artz
141 schema:givenName Andrew S.
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01341031234.28
143 rdf:type schema:Person
144 sg:person.013501676762.51 schema:affiliation https://www.grid.ac/institutes/grid.428125.8
145 schema:familyName Cunningham
146 schema:givenName John M.
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013501676762.51
148 rdf:type schema:Person
149 sg:person.016023575313.55 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
150 schema:familyName Liu
151 schema:givenName Hongtao
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016023575313.55
153 rdf:type schema:Person
154 sg:person.0661605515.11 schema:affiliation https://www.grid.ac/institutes/grid.412578.d
155 schema:familyName Stock
156 schema:givenName Wendy
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661605515.11
158 rdf:type schema:Person
159 sg:pub.10.1038/bmt.2014.9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021248967
160 https://doi.org/10.1038/bmt.2014.9
161 rdf:type schema:CreativeWork
162 sg:pub.10.1038/bmt.2015.186 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027828071
163 https://doi.org/10.1038/bmt.2015.186
164 rdf:type schema:CreativeWork
165 sg:pub.10.1038/bmt.2015.221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026646910
166 https://doi.org/10.1038/bmt.2015.221
167 rdf:type schema:CreativeWork
168 sg:pub.10.1038/sj.bmt.1704645 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026328513
169 https://doi.org/10.1038/sj.bmt.1704645
170 rdf:type schema:CreativeWork
171 sg:pub.10.1038/sj.bmt.1705011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007537088
172 https://doi.org/10.1038/sj.bmt.1705011
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1016/j.bbmt.2009.01.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001645553
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1016/j.bbmt.2009.10.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049934487
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1016/j.bbmt.2014.10.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017028738
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1016/j.bbmt.2015.11.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027956601
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1016/j.bbmt.2016.12.633 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051575972
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/j.beha.2013.10.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043563683
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/s1470-2045(09)70225-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050030568
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1182/blood-2011-01-332007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048048828
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1182/blood-2011-08-375840 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046279984
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1200/jco.1993.11.2.304 schema:sameAs https://app.dimensions.ai/details/publication/pub.1082801871
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1200/jco.2001.19.16.3675 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074864911
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1200/jco.2016.67.1875 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035196420
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1586/eci.11.24 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008619233
199 rdf:type schema:CreativeWork
200 https://www.grid.ac/institutes/grid.412578.d schema:alternateName University of Chicago Medical Center
201 schema:name Department of Medicine, Section of Hematology/Oncology, The University of Chicago Medical Center, 5841 S. Maryland, MC 2115, 60637-1470, Chicago, IL, USA
202 rdf:type schema:Organization
203 https://www.grid.ac/institutes/grid.414350.7 schema:alternateName Beijing Hospital
204 schema:name Department of Hematology, Beijing Hospital, Beijing, China
205 rdf:type schema:Organization
206 https://www.grid.ac/institutes/grid.428125.8 schema:alternateName Comer Children's Hospital
207 schema:name Department of Pediatrics, University of Chicago Comer Children’s Hospital, Chicago, IL, USA
208 rdf:type schema:Organization
209 https://www.grid.ac/institutes/grid.5386.8 schema:alternateName Cornell University
210 schema:name Division of Hematology/Oncology, Weill Cornell Medical College, New York, NY, USA
211 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...